Select language:  
1800 620 420
Close menu

Magrolimab – potential new treatment for newly diagnosed MDS

The treatment for newly diagnosed MDS will be available “very soon” to Australians in a clinical trial.

  • Clinical trials
  • Myelodysplastic syndromes
  • Research
Read more
AMLM24 Chief Investigator, Associate Professor Andrew Wei

Familial research key to blood cancer prevention strategy

The Australian Familial Haematological Cancer Study (AFHCS) leads the world in the field and has a research cohort of more than 200 families with a history of blood cancer.

  • Acute myeloid leukaemia
  • Myelodysplastic syndromes
  • Research
Read more
AFHCS research team

Christine has a rare genetic predisposition to MDS

After losing her dad to MDS, and her brother’s diagnosis just a month before hers, Christine Heath’s family underwent genomic testing to understand whether their MDS could be hereditary.  

  • Myelodysplastic syndromes
  • Myeloproliferative neoplasms
Read more
Christines-genetic-predisposition-to-MDS

MDS-survivor, Danny now dedicated to raising awareness

This MDS World Awareness Day, Danny Palmer will celebrate achieving remission after undergoing a life-saving transplant earlier this year. He’s now committed to raising awareness of the many different blood cancers, encouraging others to donate blood and plasma, as well as fundraise in support of the community.

  • Myelodysplastic syndromes
Read more
Danny Palmer

Leukaemia Foundation and HSANZ PhD scholarships to improve outcomes for people with AML and MPN

  • Media releases
  • Research
Read more

PhD scholarships focused on improving outcomes for people with AML and MPN

Basit Salik, Dr Jamie Kuzich and Dr Julian Grabek are the successful recipients of the 2021 PhD Scholarships.

  • Acute myeloid leukaemia
  • Myeloproliferative neoplasms
  • Research
Read more
Illustration of a microscope, test tubes, and clipboard

Chronic blood cancer diagnosis sparks Mel’s passion for awareness

Since receiving a shock CML diagnosis in July 2020, Mel Harris has learnt quickly that the so-called ‘invisible cancer’ can have everyday impacts beyond what many would expect.

  • Chronic myeloid leukaemia
Read more
Mel Harris

Oren fast-tracked to CAR T-cell therapy for rare Ph-like ALL

Sports-lover Oren was only the sixth child in Australia to receive CAR T-cell treatment.

  • Acute lymphoblastic leukaemia
Read more
Oren stands outside, smiling